Insulet (NASDAQ:PODD – Get Free Report) had its target price decreased by equities researchers at Morgan Stanley from $343.00 to $208.00 in a report issued on Thursday, FlyOnTheWall reports. Morgan Stanley's price target would suggest a potential upside of 10.33% from the company's current price. Other analysts also recently issued research reports about the company. […] The post Insulet (NASDAQ:PODD) Price Target Cut to $208.00 by Analysts at Morgan Stanley first appeared on Daily Political .

https://www.dailypolitical.com/2023/08/24/insulet-nasdaqpodd-price-target-cut-to-208-00-by-analysts-at-morgan-stanley.html

#dailypolitical